（横浜市立大学附属病院所属者分）
Gorur A, Patino M, Shi T, Corrales G, Takahashi H, Rangel R, Gleber-Netto FO, Pickering C, Myers JN, Cata JP: Low doses of methylnaltrexone inhibits head and neck squamous cell carcinoma growth in vitro and in vivo by acting on the mu-opioid receptor. J Cell Physiol. 236(11):7698-7710, 2021.
Gorur A, Patino M, Takahashi H, Corrales G, Pickering CR, Gleber-Netto FO, Myers JN, Cata JP: Mu-opioid receptor activation promotes in vitro and in vivo tumor growth in head and neck squamous cell carcinoma. Life Sci. 278:119541, 2021.
Hamada N, Maeda A, Takase-Minegishi K, Kirino Y, Sugiyama Y, Namkoong H, Horita N, Yoshimi R, Nakajima H; YCU irAE Working Group: Incidence and distinct features of immune checkpoint inhibitor-related myositis from idiopathic inflammatory myositis: A single-center experience with systematic literature review and meta-analysis. Front Immunol. 12:803410, 2021.
Hanai N, Shimizu Y, Kariya S, Yasumatsu R, Yokota T, Fujii T, Tsukahara K, Yoshida M, Hanyu K, Ueda T, Hirakawa H, Takahashi S, Ono T, Sano D, Yamauchi M, Watanabe A, Omori K, Yamazaki T, Monden N, Kudo N, Arai M, Sakurai D, Asakage T, Doi I, Yamada T, Homma A: Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicenter retrospective clinical study. Int J Clin Oncol. 26(3):494-506, 2021.
Hori Y, Kubota A, Yokose T, Furukawa M, Matsushita T, Katsumata N, Oridate N: Prognostic role of tumor-infiltrating lymphocytes and tumor budding in early oral tongue carcinoma. Laryngoscope. 131(11):2512-2518, 2021.
Horita N, Miyagi E, Mizushima T, Hagihara M, Hata C, Hattori Y, Hayashi N, Irie K, Ishikawa H, Kawabata Y, Kitani Y, Kobayashi N, Kobayashi N, Kurita Y, Miyake Y, Miyake K, Oguri S, Ota I, Shimizu A, Takeuchi M, Yamada A, Yamamoto K, Yukawa N, Masuda M, Oridate N, Ichikawa Y, Kaneko T: Severe anaphylaxis caused by intravenous anti-cancer drugs. Cancer Med. 10(20):7174-7183, 2021.
Hyakusoku H, Sawakuma K, Sano D, Takahashi H, Hatano T, Sato K, Isono Y, Shimada S, Takada K, Kuwahara T, Aizawa Y, Oridate N: FosL1 regulates regional metastasis of head and neck squamous cell carcinoma by promoting cell migration, invasion, and proliferation. Anticancer Res. 41(7):3317-3326, 2021.
Hyodo M, Nagao A, Asano K, Sakaguchi M, Mizoguchi K, Omori K, Tada Y, Hatakeyama H, Oridate N, Naito K, Iwata Y, Shinomiya H, Hara H, Sanuki T, Yumoto E: Botulinum toxin injection into the intrinsic laryngeal muscles to treat spasmodic dysphonia: A multicenter, placebo-controlled, randomized, double-blinded, parallel-group comparison/open-label clinical trial. Eur J Neurol. 28(5):1548-1556, 2021.
Inoue M, Yamamoto K, Hirama M, Ogahara N, Takahashi M, Oridate N: Prognostic factors of early-onset otitis media with effusion in children treated using tympanostomy. Acta Otolaryngol. 141(8):742-748, 2021.
Kariya S, Shimizu Y, Hanai N, Yasumatsu R, Yokota T, Fujii T, Tsukahara K, Yoshida M, Hanyu K, Ueda T, Hirakawa H, Takahashi S, Ono T, Sano D, Yamauchi M, Watanabe A, Omori K, Yamazaki T, Monden N, Kudo N, Arai M, Yonekura S, Asakage T, Fujiwara A, Yamada T, Homma A: Effectiveness of nivolumab affected by prior cetuximab use and neck dissection in Japanese patients with recurrent or metastatic head and neck cancer: results from a retrospective observational study in a real-world setting. Int J Clin Oncol. 26(6):1049-1056, 2021.
Kato H, Ohya T, Arai Y, Nakagawa K: Visualization of droplet spread produced by a nebulizer during the COVID-19 pandemic. QJM, 114(9): 623-624, 2021.
Lassche G, Tada Y, van Herpen CML, Jonker MA, Nagao T, Saotome T, Hirai H, Saigusa N, Takahashi H, Ojiri H, van Engen-Van Grunsven ACH, Schalken JA, Fushimi C, Verhaegh GW: Predictive and prognostic biomarker identification in a large cohort of androgen receptor-positive salivary duct carcinoma patients scheduled for combined androgen blockade. Cancers (Basel). 13(14):3527, 2021.
Mizoguchi N, Kano K, Shima S, Tsuchida K, Takakusagi Y, Serizawa I, Akahane K, Kawahara M, Yoshida M, Kitani Y, Hashimoto K, Furukawa M, Kamada T, Katoh H, Yoshida D, Shirai K: Comparison of clinical outcomes of definitive and postoperative radiotherapy for adenoid cystic carcinoma of the head and neck: Can definitive radiotherapy be a treatment option? Cancers (Basel). 13(21):5507,2021.
Nishimura G, Sano D, Arai Y, Hatano T, Takahashi H, Kitani Y, Takada K, Wada T, Oridate N: The incidence of newly diagnosed secondary cancer; Sub-analysis the prospective study of the second-look procedure for transoral surgery in patients with T1 and T2 head and neck cancer. Int J Clin Oncol, 26(1): 59-65, 2021.
Nishimura G, Sano D, Arai Y, Takahashi H, Hatano T, Kitani Y, Takada K, Wada T, Hiiragi Y, Oridate N: Validation of the risk factors for primary control of early T-stage laryngeal, oropharyngeal, and hypopharyngeal squamous cell carcinoma by transoral surgery: A prospective observational study. Int J Clin Oncol, 26(7): 1995-2003, 2021.
Oki Y, Hatakeyama H, Komatsu M, Isono Y, Ikemiyagi H, Tsukiji J, Higa R, Oridate N: A first case report of nasopharyngeal Mycobacterium abscessus subspecies massiliense infection. Eur J Med Res. 26(1):109, 2021.
Saigusa N, Hirai H, Tada Y, Kawakita D, Nakaguro M, Tsukahara K, Kano S, Ozawa H, Kondo T, Okami K, Togashi T, Sato Y, Urano M, Kajiwara M, Shimura T, Fushimi C, Shimizu A, Okamoto I, Okada T, Suzuki T, Imanishi Y, Watanabe Y, Sakai A, Ebisumoto K, Sato Y, Honma Y, Yamazaki K, Ueki Y, Hanazawa T, Saito Y, Takahashi H, Ando M, Kohsaka S, Matsuki T, Nagao T: The role of the EZH2 and H3K27me3 expression as a predictor of clinical outcomes in salivary duct carcinoma patients: A large-series study with emphasis on the relevance to the combined androgen blockade and HER2-targeted therapy. Front Oncol. 11: 779882, 2021.
Sano D, Shimizu A, Tateya I, Fujiwara K, Mori T, Miyamoto S, Nishikawa D, Terada T, Yasumatsu R, Ueda T, Matsumoto F, Kishimoto Y, Maruo T, Fujimoto Y, Tsukahara K, Yoshimoto S, Nibu KI, Oridate N: Treatment outcomes of transoral robotic and non-robotic surgeries to treat oropharyngeal, hypopharyngeal, and supraglottic squamous cell carcinoma: A multi-center retrospective observational study in Japan. Auris Nasus Larynx. 48(3):502-510, 2021.
Takada K, Aizawa Y, Sano D, Okuda R, Sekine K, Ueno Y, Yamanaka S, Aoyama J, Sato K, Kuwahara T, Hatano T, Takahashi H, Arai Y, Nishimura G, Taniguchi H, Oridate N: Establishment of PDX-derived salivary adenoid cystic carcinoma cell lines using organoid culture method. Int J Cancer. 148(1): 193-202, 2021.
Tsukamoto S, Wakui H, Azushima K, Yamaji T, Urate S, Suzuki T, Abe E, Tanaka S, Taguchi S, Yamada T, Kinguchi S, Kamimura D, Yamashita A, Sano D, Nakano M, Hashimoto T, Tamura K: Tissue-specific expression of the SARS-CoV-2 receptor, angiotensin-converting enzyme 2, in mouse models of chronic kidney disease. Sci Rep. 11(1):16843, 2021.
荒井康裕，西尾信哉，折舘伸彦，宇佐美真一: 【次世代シーケンサー時代の難聴遺伝子診断と臨床応用】先天性難聴. Otology Japan, 31(2):131-136, 2021.
荒井康裕，和田昂，森下大樹，高田顕太郎，折舘伸彦: Mycobacterium abscessusによる非結核性抗酸菌性中耳炎 症例報告と文献レビュー. Otology Japan, 31(2):194-202, 2021.
生駒亮，小林茉莉子，松浦省己，松本悠，羽田華練，河野敏朗，折舘伸彦: 鼻腔内に萌出した逆生過剰歯牙例．耳鼻臨床, 114:127-132, 2021.
稲毛まな，波多野孝，高橋秀聡，佐野大佑，徳久元彦，西村剛志，折舘伸彦: 再発転移下咽頭癌に対しニボルマブ投与後に発症した横紋筋融解症の1例. 耳鼻と臨床, 67（3）:193-199, 2021.
河野敏郎，島田翔子，鈴木一宏，石戸谷淳一，生駒亮，折舘伸彦: 自己軟膏塗布が原因と考えられた鼻中隔膿瘍例. 耳鼻咽喉科臨床, 114（7）:515-519, 2021.
塩野理，金子光裕，白石千壽瑠，逆井清，二宮啓彰，鬼島菜摘，大氣大和，青山準，山本学慧，丹羽一友，波多野孝，荒井康裕，辺照レベント，折舘伸彦: スギ花粉とダニに対する併用舌下免疫療法の方法と有害事象. 日本耳鼻咽喉科免疫アレルギー感染症学会誌, 1（3）:157-163, 2021.
羽田華練，生駒亮，松浦省己，折舘伸彦: 咽後膿瘍と鑑別を要した石灰沈着性頸長筋腱炎の1例. 口腔・咽頭科, 34（1）:109-114, 2021.
平井友梨，畠山博充，小松正規，柴田邦彦，磯野泰大，池宮城秀崇，大氣大和，鬼島菜摘，谷口彩香，福井健太，折舘伸彦: 両側下咽頭梨状陥凹瘻の1例. 頭頸部外科, 30（3）:409-414, 2021.
松浦省己，生駒亮，矢野実裕子，松本悠，羽田華練，折舘伸彦: 口蓋扁桃摘出術が著効したSAPHO症候群. 日本耳鼻咽喉科学会会報, 124（3）:225-230, 2021.
森下大樹，荒井康裕，和田昂，磯野泰大，吉田興平，折舘伸彦: 治療効果判定に異なる画像モダリティを用いた悪性外耳道炎の3症例. Otology Japan, 31（3）:293-299, 2021.
Arai Y, Sano D, Takahashi M, Nishimura G, Sakamaki K, Sakuma N, Komatsu M, Oridate N: Sphenoid sinus development in patients with acquired middle ear cholesteatoma. Auris Nasus Larynx. 47(3):391-400, 2020.
Amit M*, Takahashi H*, Dragomir MP, Lindemann A, Gleber-Netto FO, Pickering CR, Anfossi S, Osman AA, Cai Y, Wong R, Knutsen E, Shimizu M, Ivan C, Rao X, Wang J, Silverman DA, Tam S, Zhao M, Caulin C, Zinger A, Tasciotti E, Dougherty PM, El-Naggar A, Calin GA, Myers JN: Loss of p53 drives neuron reprogramming in head and neck cancer. Nature. 578(7795):449-454, 2020. *equal contribution.
Fushimi C, Okamoto I, Matsuki T, Masubuchi T, Okada T, Sato H, Tsukahara K, Kondo T, Yamashita T, Hanyu K, Omura G, Takahashi H, Tada Y, Miura K: Salvage chemotherapy after nivolumab for recurrent or metastatic head and neck carcinoma. Anticancer Res. 40(9):5277-5283, 2020.
Hirai H, Tada Y, Nakaguro M, Kawakita D, Sato Y, Shimura T, Tsukahara K, Kano S, Ozawa H, Okami K, Sato Y, Fushimi C, Shimizu A, Okamoto I, Takase S, Okada T, Sato H, Imanishi Y, Otsuka K, Watanabe Y, Sakai A, Ebisumoto K, Togashi T, Ueki Y, Ota H, Saigusa N, Takahashi H, Ando M, Urano M, Hanazawa T, Nagao T: The clinicopathological significance of the adipophilin and fatty acid synthase expression in salivary duct carcinoma. Virchows Arch. 477(2):291-299, 2020.
Hori Y, Kubota A, Yokose T, Furukawa M, Matsushita T, Oridate N: Association between pathological invasion patterns and late lymph node metastases in patients with surgically treated clinical No early oral tongue carcinoma. Head Neck. 42(2):238-243, 2020.
Inoue M, Hirama M, Kobayashi S, Ogahara N, Takahashi M, Oridate N: Long-term outcomes in children with and without cleft palate treated with tympanostomy for otitis media with effusion before the age of 2 years. Acta Otolaryngol. 140(12):982-989, 2020.
Isono Y, Furuya M, Kuwahara T, Sano D, Suzuki K, Jikuya R, Mitome T, Otake S, Kawahara T, Ito Y, Muraoka K, Nakaigawa N, Kimura Y, Baba M, Nagahama K, Takahata H, Saito I, Schmidt LS, Linehan WM, Kodama T, Yao M, Oridate N, Hasumi H: FLCN alteration drives metabolic reprogramming towards nucleotide synthesis and cyst formation in salivary gland. Biochem Biophys Res Commun. 522(4):931-938, 2020.
Kondo T, Okamoto I, Sato H, Koyama N, Fushimi C, Okada T, Masubuchi T, Miura K, Matsuki T, Yamashita T, Omura G, Takahashi H, Tsukahara K: Age-based efficacy and safety of nivolumab for recurrent or metastatic head and neck squamous cell carcinoma: A multicenter retrospective study. Asia Pac J Clin Oncol. 16(6):340-347, 2020.
Matsuki T, Okamoto I, Fushimi C, Takahashi H, Okada T, Kondo T, Sato H, Ito T, Tokashiki K, Tsukahara K, Hanyu K, Masubuchi T, Tada Y, Miura K, Omura G, Sawabe M, Kawakita D, Yamashita T: Real-World, Long-Term Outcomes of Nivolumab Therapy for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck and Impact of the Magnitude of Best Overall Response: A Retrospective Multicenter Study of 88 Patients. Cancers (Basel). 12(11):3427, 2020.
Matsushima K, Hirose H, Oridate N: Bilateral vocal fold immobility: Clinical findings of ten cases and suggested treatment options.Auris Nasus Larynx. 47(4):624-631, 2020.
Nakaguro M, Sato Y, Tada Y, Kawakita D, Hirai H, Urano M, Shimura T, Tsukahara K, Kano S, Ozawa H, Okami K, Sato Y, Fushimi C, Shimizu A, Takase S, Okada T, Sato H, Imanishi Y, Otsuka K, Watanabe Y, Sakai A, Ebisumoto K, Togashi T, Ueki Y, Ota H, Saigusa N, Takahashi H, Ando M, Hanazawa T, Nagao T. Prognostic Implication of Histopathologic Indicators in Salivary Duct Carcinoma: Proposal of a Novel Histologic Risk Stratification Model. Am J Surg Pathol. 44(4):526-535, 2020.
Nakayama M, Orosco RK, Holsinger FC, Spriano G, Succo G, De Virgilio A, Oridate N: Endoscopic Transoral Hybrid Supracricoid Partial Laryngectomy with Cricohyoidoepiglottopexy. Ann Otol Rhinol Laryngol. 129(3):273-279, 2020.
Niwa K, Kawakita D, Nagao T, Takahashi H, Saotome T, Okazaki M, Yamazaki K, Okamoto I, Hirai H, Saigusa N, Fushimi C, Masubuchi T, Miura K, Okazaki SI, Matsui H, Okada T, Iwaki S, Matsuki T, Hanyu K, Tsukahara K, Oridate N, Tada Y: Multicentre, retrospective study of the efficacy and safety of nivolumab for recurrent and metastatic salivary gland carcinoma. Sci Rep. 10(1):16988, 2020.
Oki Y, Hatakeyama H, Ikemiyagi H, Isono Y, Komatsu M, Oridate N: Intraductal carcinoma of the parotid gland presenting as parapharyngeal space. Biomedicine Hub. 5(3):211677, 2020.
Saito Y, Hayashi R, Iida Y, Mizumachi T, Fujii T, Matsumoto F, Beppu T, Yoshida M, Shinomiya H, Kamiyama R, Kitano M, Yokoshima K, Fujimoto Y, Hama T, Yamashita T, Okami K, Miura K, Fujisawa T,Sano D, Kato H, Minami S, Sugasawa M, Masuda M, Ota I, Iwae S, Kawata R, Monden N, Imai T, Asakage T, Okada M, Yoshikawa T, Tanioka K, Kitayama M, Doi M, Fujii S, Fujii M, Oridate N, Nakamizo M, Yoshimoto S, Homma A, Nibu KI, Yane K: Optimization of therapeutic strategy for p16-positive oropharyngeal squamous cell carcinoma: Multi-institutional observational study based on the national head and neck cancer registry of Japan. Cancer. 126;4177-4187, 2020.
Sano D, Matsushima K, Isono Y, Ikui Y, Kinutani Y, Chiba Y, Hirose H, Oridate N: Long-term treatment outcome of type 1 thyroplasty using novel titanium medialization laryngoplasty implant combined with arytenoid adduction for unilateral vocal cord paralysis: single-arm interventional study at a single institution. Laryngoscope Investig Otolaryngol. 5(5);895–902, 2020.
荒井康裕, 和田昂, 折舘伸彦: 分子標的治療に至ったコントロール不要の好酸球性中耳炎症例. アレルギーの臨床, 40(12):1047-1048, 2020.
荒井康裕, 和田昂, 折舘伸彦: コントロール不良の好酸球性中耳炎症例. アレルギーの臨床, 40(9):742-744, 2020.
生駒亮, 矢野実裕子, 折舘伸彦: Endoscopic modified medial maxillectomyを施行した上顎洞含歯性嚢胞例. 頭頸部外科, 30:87-92, 2020.
髙尾なつみ, 榎本浩幸, 木谷有加, 田中恭子, 井上真規, 小林眞司, 折舘伸彦: アデノイド切除術後に開鼻声を生じ外科的治療を必要とした小児例. 日本耳鼻咽喉科学会会報, 123(5):371-376, 2020.
田中文平, 生駒亮, 松浦省己, 松本悠, 河野敏朗, 折舘伸彦: 鈍的外傷後に生じた深頸部膿瘍例. 耳鼻咽喉科臨床, 113(4):265-269, 2020.
平井友梨, 畠山博充, 小松正規, 柴田邦彦, 磯野泰大, 池宮城秀崇, 大氣大和, 鬼島菜摘, 谷口彩香, 福井健太, 折舘伸彦: 両側下咽頭梨状陥凹瘻の1例. 頭頸部外科, 30(3):409-414, 2020.
森下大樹, 佐野大佑, 荒井康裕, 磯野泰大, 田辺輝彦, 稲毛まな, 折舘伸彦: 吹奏楽器演奏時における鼻咽腔閉鎖機能不全に対して上咽頭脂肪注入が奏効した例. 日本耳鼻咽喉科学会会報, 123(3):251-256, 2020.
Amit M, Abedelmeguid AS, Watcherporn T, Takahashi H, Tam S, Bell D, Ferrarotto R, Glisson B, Kupferman M, Roberts D, Su SY, Raza S, DeMonte F, Hanna EY: Induction chemotherapy response as a guide for treatment optimization in sinonasal undifferentiated carcinoma. J Clin Oncol, 37(6): 504-512, 2019.
Amit M, Tam S, Takahashi H, Choi KY, Zafereo M, Bell D, Weber RS: Prognostic performance of the American Joint Committee on Cancer 8th edition of the TNM staging system in patients with early oral tongue cancer. Head Neck, 41(5): 1270-1276, 2019.
Burtness B, Harrington KJ, Greil R, Soulières D, Tahara M, de Castro G Jr, Psyrri A, Basté N, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesía R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Hong RL, González Mendoza R, Roy A, Zhang Y, Gumuscu B, Cheng JD, Jin F, Rischin D; KEYNOTE-048 Investigators: Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Lancet, 394(10212):1915-1928, 2019.
Lindemann A, Patel AA, Silver NL, Tang L, Liu Z, Wang L, Tanaka N, Rao X, Takahashi H, Maduka NK, Zhao M, Chen TC, Liu W, Gao M, Wang J, Frank SJ, Hittelman WN, Mills GB, Myers JN, Osman AA: COTI-2, A novel Thiosemicarbazone derivative, exhibits antitumor ativity in HNSCC through p53-dependent and -independent mchanisms. Clin Cancer Res, 25(18): 5650-5662, 2019.
Matsuki T, Miura K, Tada Y, Masubuchi T, Fushimi C, Kanno C, Takahashi H, Kamata S, Okamoto I, Miyamoto S, Yamashita T: Classification of tumors by imaging diagnosis and preoperative fine-needle aspiration cytology in 120 patients with tumors in the parapharyngeal space. Head Neck, 41(5): 1277-1281, 2019.
Nishimura G, Sano D, Arai Y, Hatano T, Takahashi H, Tanabe T, Wada T, Morishita D, Oridate N: A prospective clinical trial of the second-look procedure for transoral surgery in patients with T1 and T2 laryngeal, oropharyngeal, and hypopharyngeal cancer. Cancer Med, 8(17): 7197-7206, 2019.
Okada T, Saotome T, Nagao T, Masubuchi T, Fushimi C, Matsuki T, Takahashi H, Miura K, Tsukahara K, Tada Y: Carboplatin and docetaxel in patients with salivary gland carcinoma: a retrospective study. In Vivo, 33(3): 843-853, 2019.
Sano D, Fujisawa T, Tokuhisa M, Shimizu M, Sakagami T, Hatano T, Nishimura G, Ichikawa Y, Iwai H, Oridate N: Real-world treatment outcomes of the EXTREME regimen as first-line therapy for recurrent/metastatic squamous cell carcinoma of the head and neck: a multi-center retrospective cohort study in Japan. Anticancer Res, 39(12): 6819-6827, 2019.
Sano D, Tanabe T, Kubota A, Miyamoto S, Tanigaki Y, Okami K, Komatsu M, Ikoma R, Suzuki K, Akazawa Y, Kobayashi S, Yamada Y, Oridate N. Addition of S-1 to radiotherapy for treatment of T2N0 glottic cancer: Results of the multiple-center retrospective cohort study in Japan with a propensity score analysis. Oral Oncol, 99: 104454, 2019.
Takahashi H, Tada Y, Saotome T, Akazawa K, Ojiri H, Fushimi C, Masubuchi T, Matsuki T, Tani K, Osamura R, Hirai H, Yamada S, Kawakita D, Miura K, Kamata S, Nagao T: Phase II trial of trastuzumab and docetaxel in patients with human epidermal growth factor receptor 2-positive salivary duct carcinoma. J Clin Oncol, 37(2): 125-134, 2019.
荒井康裕, 森下大樹, 磯野泰大, 和田 昂, 佐久間直子, 高橋優宏, 宇佐美真一, 折舘伸彦: 言語習得後失聴成人患者にたいする非良聴耳への人工内耳の聴取成績の検討. Otology Japan, 29(2):185-192, 2019.
生駒 亮，松浦省己，折舘伸彦: 塞栓術を施行せずに摘出した鼓室型グロームス腫瘍例．耳鼻臨床, 112(7): 425-431，2019.
河野敏朗, 湯田恵子, 生駒 亮, 石戸谷淳一, 桑原 達, 折舘伸彦: 3者併用療法による突発性難聴 Grade 4 の予後因子について～続報～. 日本耳鼻咽喉科学会会報, 122(5): 757-763, 2019.
北川有希子, 谷垣裕二, 折舘伸彦: 頸部リンパ節腫脹から診断に至った梅毒例. 耳鼻咽喉科臨床, 112(12): 833-836, 2019.
木谷有加, 畠山博充, 小松正規, 佐久間直子, 柴田邦彦, 木谷洋輔, 笠井理行, 松本 悠, 井上綾佳, 折舘伸彦: 過大なカフ圧および気管カニューレの固定不良により椎体変形を来した筋ジストロフィー症例. 日本耳鼻咽喉科学会会報, 122(9): 1229-1234, 2019.
佐野大佑, 青山 準, 折舘伸彦: 根治手術として喉頭摘出を要した局所進行喉頭・下咽頭扁平上皮癌患者に対する予後予測における炎症性マーカーの有用性. 喉頭, 31(2): 157-162, 2019.
佐野大佑，矢吹健一郎，高橋秀聡，荒井康裕，千葉欣大，田辺輝彦，西村剛志，折舘伸彦: ANL Secondary Publication 頭頸部扁平上皮癌の予後予測におけるLymph node ratioの有用性. 日本耳鼻咽喉科学会会報, 122(9): 1009-1010, 2019.
高尾なつみ, 千葉欣大, 佐野大佑, 折舘伸彦: 消化器疾患術後の嚥下障害患者における嚥下内視鏡検査による経口摂取確立の予測. 日本耳鼻咽喉科学会会報, 122(10): 1304-1313, 2019.
松下武史, 荒井康裕, 折舘伸彦: 副鼻腔炎に合併した眼窩血性嚢胞．日本医事新報，4991: 12-13, 2019.
和田 昂, 荒井康裕, 折舘伸彦: 臨床各科 難渋症例から学ぶ診療のエッセンス(File 70) 成人後に反復性髄膜炎を生じた内耳奇形症例. 日本医事新報, 4984: 12-13, 2019.
